Author Archives: admin


Key finding in stem cell self-renewal

ScienceDaily (Feb. 6, 2012) — A University of Minnesota-led research team has proposed a mechanism for the control of whether embryonic stem cells continue to proliferate and stay stem cells, or differentiate into adult cells like brain, liver or skin.

The work has implications in two areas. In cancer treatment, it is desirable to inhibit cell proliferation. But to grow adult stem cells for transplantation to victims of injury or disease, it would be desirable to sustain proliferation until a sufficient number of cells have been produced to make a usable organ or tissue.

The study gives researchers a handle on how those two competing processes might be controlled. It was performed at the university's Hormel Institute in Austin, Minn., using mouse stem cells. The researchers, led by Hormel Institute Executive Director Zigang Dong and Associate Director Ann M. Bode, have published a report in the journal Nature: Structure and Molecular Biology.

"This is breakthrough research and provides the molecular basis for development of regenerative medicine," said Dong. "This research will aid in the development of the next generation of drugs that make repairs and regeneration within the body possible following damage by such factors as cancer, aging, heart disease, diabetes, or paralysis caused by traumatic injury."

The mechanism centers on a protein called Klf4, which is found in embryonic stem cells and whose activities include keeping those cells dividing and proliferating rather than differentiating. That is, Klf4 maintains the character of the stem cells; this process is called self-renewal. The researchers discovered that two enzymes, called ERK1 and ERK2, inactivate Klf; this allows the cells to begin differentiating into adult cells.

The two enzymes are part of a "bucket brigade" of signals that starts when a chemical messenger arrives from outside the embryonic stem cells. Chemical messages are passed to inside the cells, resulting in, among other things, the two enzymes swinging into action.

The researchers also discovered how the enzymes control Klf4. They attach a small molecule--phosphate, consisting of phosphorus and oxygen--to Klf4. This "tag" marks it for destruction by the cellular machinery that recycles proteins.

Further, they found that suppressing the activity of the two enzymes allows the stem cells to maintain their self-renewal and resist differentiation. Taken together, their findings paint a picture of the ERK1 and ERK2 enzymes as major players in deciding the future of embryonic stem cells--and potentially cancer cells, whose rapid growth mirrors the behavior of the stem cells.

Klf4 is one of several factors used to reprogram certain adult skin cells to become a form of stem cells called iPS (induced pluripotent stem) cells, which behave similarly to embryonic stem cells. Also, many studies have shown that Klf4 can either activate or repress the functioning of genes and, in certain contexts, act as either an oncogene (that promotes cancer) or a tumor suppressor. Given these and their own findings reported here, the Hormel Institute researchers suggest that the self-renewal program of cancer cells might resemble that of embryonic stem cells.

"Although the functions of Klf4 in cancer are controversial, several reports suggest Klf4 is involved in human cancer development," Bode said.

Recommend this story on Facebook, Twitter,
and Google +1:

Other bookmarking and sharing tools:

Story Source:

The above story is reprinted from materials provided by University of Minnesota.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.

Journal Reference:

Myoung Ok Kim, Sung-Hyun Kim, Yong-Yeon Cho, Janos Nadas, Chul-Ho Jeong, Ke Yao, Dong Joon Kim, Dong-Hoon Yu, Young-Sam Keum, Kun-Yeong Lee, Zunnan Huang, Ann M Bode, Zigang Dong. ERK1 and ERK2 regulate embryonic stem cell self-renewal through phosphorylation of Klf4. Nature Structural & Molecular Biology, 2012; DOI: 10.1038/nsmb.2217

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

Link:
Key finding in stem cell self-renewal

Acid attack survivor Katie Piper has eye-sight restored after stem-cell surgery

By Tara Brady

Last updated at 6:06 PM on 5th February 2012

A former model and television presenter who was left partially blind in one eye after an acid attack has had her sight restored following stem-cell surgery.

Katie Piper, 29, suffered third degree burns and had to have her face reconstructed after the attack in 2008, when her spurned ex-boyfriend, Daniel Lynch, 35, arranged for Stefan Sylvestre, 22, to throw acid in her face.

The incident left her scarred for life and damaged her left eye.

Winning again: Katie Piper is enjoying having her sight back following acid attack in 2008

Katie has had hundreds of plastic surgery operations, including skin grafts to remould the skin around her eyes.

She also had to wear a mask for 23 hours a day to stretch her scar tissue. 

But her sight has now been restored thanks to doctors at the Queen Victoria hospital in East Grinstead, West Sussex, who used eye tissue from the cornea of an anonymous male donor.

 

The cells then grew and three weeks later were stitched into Piper's damaged eye.

Her eye was then covered with amniotic membrane - womb lining donated by women who have had caesarean births which acted as a bandage.

Speaking to the Sunday Times, Katie said: 'It has been an amazing feeling.

'It wasn't like I took the bandage off and my sight came back like that, it happened gradually.

Inspiration: Ex-model and TV presenter Katie Piper who had acid thrown into her face

'But after three weeks I started to see results. I'd seen a lot of progress with my scars, but my sight was the one injury I'd say to myself was permanent and least expected to change. I do feel like I'm winning.'

Sheraz Daya, the surgeon who led the team, has successfully treated more than 60 patients with the procedure.

He said: 'Our goal is to make sure the cornea heals. The best part of it is that it begins to clear and sight is restored.' 

Katie: The Science of Seeing Again will be shown on Channel 4 at 9pm on Tuesday.

 

Read more:
Acid attack survivor Katie Piper has eye-sight restored after stem-cell surgery

Katie Piper: Acid attack survivor has eye-sight restored after stem-cell surgery

By Tara Brady

Last updated at 6:06 PM on 5th February 2012

A former model and television presenter who was left partially blind in one eye after an acid attack has had her sight restored following stem-cell surgery.

Katie Piper, 29, suffered third degree burns and had to have her face reconstructed after the attack in 2008, when her spurned ex-boyfriend, Daniel Lynch, 35, arranged for Stefan Sylvestre, 22, to throw acid in her face.

The incident left her scarred for life and damaged her left eye.

Winning again: Katie Piper is enjoying having her sight back following acid attack in 2008

Katie has had hundreds of plastic surgery operations, including skin grafts to remould the skin around her eyes.

She also had to wear a mask for 23 hours a day to stretch her scar tissue. 

But her sight has now been restored thanks to doctors at the Queen Victoria hospital in East Grinstead, West Sussex, who used eye tissue from the cornea of an anonymous male donor.

 

The cells then grew and three weeks later were stitched into Piper's damaged eye.

Her eye was then covered with amniotic membrane - womb lining donated by women who have had caesarean births which acted as a bandage.

Speaking to the Sunday Times, Katie said: 'It has been an amazing feeling.

'It wasn't like I took the bandage off and my sight came back like that, it happened gradually.

Inspiration: Ex-model and TV presenter Katie Piper who had acid thrown into her face

'But after three weeks I started to see results. I'd seen a lot of progress with my scars, but my sight was the one injury I'd say to myself was permanent and least expected to change. I do feel like I'm winning.'

Sheraz Daya, the surgeon who led the team, has successfully treated more than 60 patients with the procedure.

He said: 'Our goal is to make sure the cornea heals. The best part of it is that it begins to clear and sight is restored.' 

Katie: The Science of Seeing Again will be shown on Channel 4 at 9pm on Tuesday.

 

Read the rest here:
Katie Piper: Acid attack survivor has eye-sight restored after stem-cell surgery

Bonita stem cell doctor's attorney quits, state hearing still scheduled

Interview with Dr. Zannos Grekos Grekos contests that his office has done ...

The state took action against Dr. Zannos Grekos because of the death of a 69-year-old breast cancer patient April 4, 2010, after undergoing the treatment at his Bonita Springs practice, at 9500 Bonita Beach Road, Suite 310.

BONITA SPRINGS — Dr. Zannos Grekos may not have an attorney representing him at a hearing next month against a state complaint that he performed an unauthorized stem cell procedure on a patient who later died.

Or maybe the Bonita Springs cardiologist will have new counsel for the three-day administrative hearing scheduled to begin March 20.

His original attorney, Greg Chaires of Orlando, withdrew from the case Jan. 24, less than two months before the hearing. He's been Grekos' attorney since the state filed an administrative complaint against the doctor a year ago.

Grekos couldn't be reached for comment at his practice, Regenocyte Therapeutic, 9500 Bonita Beach Road, Suite 310.

Chaires stated in his withdrawal notice to the judge that he had good cause to stop representing him, but didn't elaborate.

Florida health department spokeswoman Jennifer Hirst said this past week that Grekos has two weeks to hire a new attorney "and regardless of whether he does or not, the trial date will not change."

The case, which stems from events in early 2010, culminated a year later on Feb. 22, 2011, when the health department imposed an emergency restriction against his license. The restriction prohibits him from doing any procedures with bone marrow or stem cells in his practice.

If the administrative law judge sides with the state, Grekos could face sanctions or permanent restriction or revocation of his license.

At issue was Grekos' treatment of a 69-year-old woman who went to him for a consult on Feb. 25, 2010, for numbness and tingling in her arms and legs after chemotherapy.

Grekos ordered imaging of her carotid arteries and her brain and later injected her own aspirated bone marrow into her cerebral circulatory system.

At home that evening, she fell and was hospitalized. She had suffered a severe brain stem injury and was taken off life support on April 2, 2010.

Licensed in Florida since 1992, Grekos' cardiology practice in recent years has focused more on stem cell therapy to repair damaged heart muscle, lungs and other tissue.

He sends a sample of a patient's lung to Israel to cultivate new stem cells and the blood gets sent to a clinic or hospital in the Dominican Republic. The patient travels to the Dominican Republic, where the stem cells are injected into the damaged tissue.

Grekos has established a relationship with doctors and clinicians in the Dominican Republic who do the injections on his behalf; he isn't licensed to practice medicine there.

The case has captured widespread attention among Grekos' supporters who swear their once-chronic illnesses have undergone dramatic improvement since having the therapy through him. Detractors say he is taking advantage of a vulnerable population with congestive heart failure, lung failure and other illnesses for which conventional treatments no longer are effective.

See the article here:
Bonita stem cell doctor's attorney quits, state hearing still scheduled

NOC Interview 2: Big Pharma – Video

01-02-2012 21:36 Notes from the interview: Nicholas Anderson - Author, NOC: British Secret Operations Big Pharma... must be careful in discussing reason for writing books is in part because of something along these lines medical doctor helped to exfiltrate from soviet union end of 1991 doctor wanted to meet... nicholas anderson flew to meet in moscow... bottom line: he claimed to have number of effective treatments and cures... MIND YOU... he's not trying to get your hopes up, but you should look into alternate treatments natural remedies. stem cell, energetic medicine is more detail in the book? when the book was written, it was non-fiction. but it didn't last to be a non-fiction novel. former secret operations must be cleared. large majority that was redacted or cleared from the fiction novel was about big pharma. certain things -are- in the book. also know that nicholas anderson was skeptical about these items first. even so, he wondered why aren't these alternative cures more widely known? the doctor appeared on a primetime show and the media prevented him from saying what he wanted to say... in a couple examples, they removed things he had said. they said the -opposite- of what he actually said. it was then that he realized he was on to something and he saw that happening. did this doctor have access to this medicine in the soviet union or was it secretive? in the beginning of communism, they did come up with things in medicine that the west never did come up with. this doctor had ...

Read the original:
NOC Interview 2: Big Pharma - Video

Stoney Creek firm licenses stem cell technology

New York-based IntelliCell BioSciences has licensed its patent-pending technology for the manufacture of stem cells to RegenaStem Inc., based in Stoney Creek. Under the agreement, the company name, RegenaStem, will be changed to IntelliCell BioSciences of Canada. According to company president, Jason Kane, talks are under way with Health Canada to begin manufacturing stem cells and using the technology to treat people with degenerative joint disease, such as arthritis. The treatment is designed to rebuild and repair cartilage and tissue. Clinical trials are set to begin this year. Other applications are also being planned.

Kane’s background in stem cell work includes leading the launch of the first in-clinic stem cell therapy kits for veterinarians in Canada. For more information, call 289-887-5195 or email jkane@intellicellbiosciences.ca

Construction association members honoured

The Hamilton-Halton Construction Association (HHCA) will honour eight of its members for their achievements in health and safety during the association’s annual general meeting next week.

The recipients of the 2011 awards are Comstock Canada, Lancaster Sheet Metal, Barclay Construction, McGowan Insulations, Safway Services Canada, John Kenyon Limited, Brand/Aluma Enterprises and B&G Roofing and Sheet Metal.

Also during the meeting, Ted Wyatt — who has been involved in the local construction industry since the 1950s — will be inducted in to the Construction Hall of Fame. Ron Worrall will receive the Young Leader Award.

The incoming president of the HHCA is Jim DiNovo, president of BML Multi Trades Group Ltd. in Brantford. He takes over for outgoing president Domenic Mattina, vice-president at Mattina Mechanical Limited.

Tricia Hellingman is president of Hellingman Communications, a Hamilton-based public relations and marketing agency. Bizz Buzz welcomes submissions from the business community. Contact thellingman@hellingman.com.

Read the original here:
Stoney Creek firm licenses stem cell technology

Parkinson’s Disease: Progress and Promise in Stem Cell Research – Video

26-08-2009 17:24 Parkinson's disease is a neurodegenerative disease that affects nearly a million people in the United States. The symptoms include tremors, slow movement, muscle rigidity and less facial expression. No cure exists for the disease and current medications become less effective over time. William Langston, CEO and scientific director of the Parkinson's Institute, discusses stem cell-based research strategies to better understand the disease and to find new therapies. The Parkinson's Institute has an Early Translation grant from CIRM.

Read more from the original source:
Parkinson's Disease: Progress and Promise in Stem Cell Research - Video